HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Norimitsu Inoue Selected Research

Interferon-gamma (Interferon, gamma)

1/2017Development of effective tumor immunotherapy using a novel dendritic cell-targeting Toll-like receptor ligand.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Norimitsu Inoue Research Topics

Disease

22Neoplasms (Cancer)
01/2022 - 12/2006
7Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
11/2020 - 04/2002
7Inflammation (Inflammations)
08/2020 - 06/2008
6Atypical Hemolytic Uremic Syndrome
01/2024 - 01/2019
6Thrombotic Microangiopathies
12/2023 - 01/2019
4Squamous Cell Carcinoma of Head and Neck
11/2022 - 06/2017
4Hemolysis
12/2019 - 12/2002
3Infections
04/2021 - 06/2016
2Hereditary Complement Deficiency Diseases
11/2023 - 04/2021
2Thrombocytopenia (Thrombopenia)
11/2023 - 12/2021
2Thrombotic Thrombocytopenic Purpura
01/2019 - 01/2019
1Lymphedema (Milroy Disease)
11/2023
1Guillain-Barre Syndrome
01/2023
1Neuromyelitis Optica (Devic's Disease)
01/2023
1Myasthenia Gravis
01/2023
1Mitochondrial Diseases (Mitochondrial Disease)
12/2022
1Moyamoya Disease (Moya-Moya Disease)
08/2022
1Complement Component 6 Deficiency
08/2022
1Erectile Dysfunction
01/2022
1Exanthema (Rash)
12/2021
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2021
1Hemolytic Anemia
12/2021
1Rare Diseases (Rare Disease)
12/2021
1Hemorrhage
01/2020
1Meningococcal Infections
01/2019
1Head and Neck Neoplasms (Head and Neck Cancer)
06/2017
1Acute-Phase Reaction
02/2017
1Infantile Spasms (West Syndrome)
03/2014
1Hyperphosphatasia with Mental Retardation
03/2014
1Epilepsy (Aura)
10/2013
1Hereditary Angioedemas
12/2012

Drug/Important Bio-Agent (IBA)

12Complement System Proteins (Complement)IBA
01/2024 - 12/2002
7Lactic Acid (Lactate)FDA LinkGeneric
11/2022 - 06/2008
7Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA
11/2020 - 04/2002
6eculizumabFDA Link
01/2023 - 01/2019
6LigandsIBA
01/2022 - 06/2008
5Proteins (Proteins, Gene)FDA Link
08/2022 - 04/2002
5Glucose (Dextrose)FDA LinkGeneric
08/2020 - 06/2008
4Toll-Like Receptors (Toll-Like Receptor)IBA
01/2022 - 07/2007
4CytokinesIBA
05/2018 - 10/2010
3Neoplasm Antigens (Tumor Antigens)IBA
01/2022 - 12/2014
2Complement Factor H (Factor H)IBA
01/2024 - 12/2021
2Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2021
2Monoclonal AntibodiesIBA
01/2023 - 06/2019
2VitaminsIBA
12/2022 - 10/2013
2NucleotidesIBA
04/2021 - 01/2020
2Peptides (Polypeptides)IBA
01/2020 - 05/2018
2LipopeptidesIBA
05/2018 - 12/2014
2VaccinesIBA
05/2018 - 09/2010
2Immunologic Adjuvants (Immunologic Adjuvant)IBA
12/2014 - 07/2010
2Interleukin-23 (Interleukin 23)IBA
01/2011 - 06/2008
1LectinsIBA
11/2023
1chemotactic factor inactivatorIBA
11/2023
1Complement Factor I (C3b Inactivator)IBA
11/2023
1Antihypertensive Agents (Antihypertensives)IBA
11/2023
1Riboflavin (Vitamin B2)FDA LinkGeneric
12/2022
1Flavin-Adenine Dinucleotide (FAD)IBA
12/2022
1Flavin Mononucleotide (FMN)IBA
12/2022
1PyridoxalIBA
12/2022
1Succinic Acid (Succinate)IBA
11/2022
1S-Adenosylmethionine (Ademetionine)IBA
11/2022
1alpha-hydroxyglutarateIBA
11/2022
1EnzymesIBA
11/2022
1Glutathione (Reduced Glutathione)IBA
11/2022
1Glutamine (L-Glutamine)FDA Link
11/2022
1Complement C6 (Complement 6)IBA
08/2022
1AndrogensIBA
01/2022
1PolymersIBA
01/2022
1AntigensIBA
01/2022
1Liposomes (Liposome)IBA
01/2022
1AntibodiesIBA
12/2021
1Complement C7 (Complement 7)IBA
04/2021
1Complement Factor B (Factor B)IBA
01/2021
1Fluorine-18IBA
08/2020
1Indicators and Reagents (Reagents)IBA
08/2020
1LipidsIBA
01/2020
1Oxygen (Dioxygen)IBA
01/2020
1Amino AcidsFDA Link
01/2020
1InflammasomesIBA
12/2019
1GPI-Linked ProteinsIBA
12/2019
1Factor V (Coagulation Factor V)IBA
06/2019
1Cancer VaccinesIBA
05/2018
1Serine (L-Serine)FDA Link
05/2018
1Toll-Like Receptor 2IBA
05/2018
1Arginine (L-Arginine)FDA Link
05/2018
1Lysine (L-Lysine)FDA Link
05/2018
1InterferonsIBA
05/2018
1Therapeutic UsesIBA
01/2017
1Interferon-gamma (Interferon, gamma)IBA
01/2017
1C-Reactive ProteinIBA
06/2016
1Immunoglobulin D (IgD)IBA
03/2014
1CD40 Ligand (CD40L)IBA
11/2013
1IFIH1 Interferon-Induced HelicaseIBA
02/2012
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
02/2012
1Toll-Like Receptor 3IBA
02/2012

Therapy/Procedure

9Immunotherapy
01/2022 - 07/2007
6Therapeutics
11/2023 - 12/2008
2Kidney Transplantation
12/2023 - 12/2023
1Hematopoietic Stem Cell Transplantation
01/2021
1Laughter Therapy
01/2019